Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs Amylx Pharmaceuticals Inc (AMLX) Price & Performance

Abeona Therapeutics IncTrade
Amylx Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs Amylx Pharmaceuticals Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B). The key difference: Amylx Pharmaceuticals Inc is far larger — about 6.3× Abeona Therapeutics Inc's market cap. Which is the better fit depends on your goals.

ABEOAMLX
Market Cap
$421.19M$2.64B
Sector
HealthHealth
52-Week High
$7.45$24.19
52-Week Low
$4.17$7.82
Enterprise Value
$276.10M$2.39B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX